首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1608709

內分泌檢測產品市場：依產品類型、按技術、按適應症、按最終用戶、按地區

Endocrine Testing Product Market, By Product Type, By Technology, By Disease Indication, By End User, By Geography

出版日期: 2024年11月11日 | 出版商:

Coherent Market Insights | 英文 208 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

內分泌檢測產品市場預計到2024年將達到136.9億美元，預計到2031年將達到253.4億美元，2024年至2031年的複合年成長率為9.2%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	136.9億美元
實際資料	2019-2023	預測期	2024-2031
預測 2024-2031 年複合年成長率：	9.20%	2031年價值預測	253.4億美元

圖：2024 年按地區分類的內分泌檢測產品市場佔有率（%）

內分泌檢測產品是用於內分泌系統功能檢測的體外診斷試劑。內分泌系統是由腺體組成的調節系統，將荷爾蒙直接分泌到循環系統中，以調節遠處的目標器官。內分泌檢測產品可幫助醫生監測荷爾蒙水平並篩檢內分泌失調。常見的內分泌測試包括甲狀腺功能測試、睪固酮測試、雌激素測試、催乳素測試、皮質醇測試和胰島素測試。糖尿病、甲狀腺疾病和荷爾蒙失衡等內分泌相關疾病的盛行率不斷上升，可能會推動全球對內分泌檢測的需求。診斷技術的進步促進了臨床實驗室高通量內分泌檢測的高靈敏度生物檢測和自動化解決方案的開發。

市場動態

全球內分泌檢測產品市場的成長是由越來越多的老齡化人口（更容易患內分泌疾病）、人們對內分泌疾病的認知和篩檢的提高以及內分泌功能檢測在疾病診斷和管理中的廣泛應用推動的。然而，新產品核可的漫長而複雜的監管流程以及不願改變現有測試程序可能會阻礙市場成長。市場正在見證先進免疫檢測平台的開發帶來的利潤豐厚的機會，這些平台具有更高的準確性、每次測試的測試量更大以及整合的資訊學。這使得可以用小樣本同時測試多種荷爾蒙。

本研究的主要特點

該報告對全球內分泌檢測產品市場進行了詳細分析，並提出了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球內分泌檢測產品市場的主要企業進行了分析。

本研究涵蓋的主要企業包括 Abbott、AB Sciex、Agilent Technologies Inc.、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Quest Diagnostics Inc.、Danaher、Immunodiagnostic Systems、Fujirebio 、公司等

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球內分泌檢測產品市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球內分泌檢測產品市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	13.69 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.20%	2031 Value Projection:	25.34 Bn

Endocrine testing product refers to in vitro diagnostics that are used to test the functionality of the endocrine system. Endocrine system is a regulatory system composed of glands that secrete hormones directly into the circulatory system to regulate distant target organs. Endocrine testing products help physicians monitor hormone levels and screen for endocrine disorders. Some common endocrine tests include thyroid function tests, testosterone testing, estrogen testing, prolactin testing, cortisol testing, and insulin testing. Rising prevalence of endocrine-related diseases such as diabetes, thyroid disorders, and hormonal imbalance disorders can boost demand for endocrine testing worldwide. Advancements in diagnostic technologies have enabled the development of sensitive bioassays and automated solutions for high-throughput endocrine testing in clinical laboratories.

Market Dynamics

Global endocrine testing product market growth is driven by growing geriatric population who are more prone to developing endocrine disorders, increasing awareness and screening of endocrine conditions, and expanding applications of endocrine function tests in disease diagnosis and management. However, lengthy and complex regulatory processes for new product approvals and reluctance to change existing testing procedures can hamper the market growth. The market witness lucrative opportunities from the development of advanced immunoassay platforms with improved accuracy, high test volumes per run, and integrated informatics. This allows for the testing of multiple hormones simultaneously using small sample volumes.

Key Features of the Study

This report provides in-depth analysis of the global endocrine testing product market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global endocrine testing product market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, Immunodiagnostic Systems, and Fujirebio, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global endocrine testing product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing product market

Market Segmentation

By Product Type Insights
- Instruments/Analyzers
- Consumables
By Technology Insights
- Liquid Chromatography-Mass Spectrometry
- Immunoassay
- Tandem Mass Spectroscopy
- Sensor Technology
- Others
By Disease Indication Insights
- Adrenal Insufficiency and Addison Disease
- Bone Disorders
- Cancer
- Thyroid Disease
- Others
By End User Insights
- Hospitals
- Clinical Laboratories
- Others
Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Abbott
- AB Sciex
- Agilent Technologies Inc.
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd.
- Quest Diagnostics Inc
- Danaher
- Immunodiagnostic Systems
- Fujirebio, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Endocrine Testing Product Market, By Product Type
- Endocrine Testing Product Market, By Technology
- Endocrine Testing Product Market, By Disease Indication
- Endocrine Testing Product Market, By End User
- Endocrine Testing Product Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology
Pipeline Analysis

4. Endocrine Testing Product Market, By Product Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Instruments/Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Endocrine Testing Product Market, By Technology, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Liquid Chromatography-Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunoassay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Tandem Mass Spectroscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Sensor Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Endocrine Testing Product Market, By Disease Indication, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Adrenal Insufficiency and Addison Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Bone Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Thyroid Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Endocrine Testing Product Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Endocrine Testing Product Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa

9. Competitive Landscape

Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AB Sciex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DiaSorin S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F.Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Quest Diagnostics Inc
Danaher
Immunodiagnostic Systems
Fujirebio, Inc.